These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15831904)

  • 1. Risk of haematopoietic cancer in patients with inflammatory bowel disease.
    Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
    Gut; 2005 May; 54(5):617-22. PubMed ID: 15831904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Risk for Hematological Malignancies in Inflammatory Bowel Disease: A Nationwide Population-based Study in Taiwan.
    Wang LH; Yang YJ; Cheng WC; Wang WM; Lin SH; Shieh CC
    Am J Gastroenterol; 2016 Sep; 111(9):1313-9. PubMed ID: 27296944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory bowel diseases increase future ischemic stroke risk: a Taiwanese population-based retrospective cohort study.
    Huang WS; Tseng CH; Chen PC; Tsai CH; Lin CL; Sung FC; Kao CH
    Eur J Intern Med; 2014 Jul; 25(6):561-5. PubMed ID: 24906568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
    Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
    Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease in Iran: a review of 457 cases.
    Aghazadeh R; Zali MR; Bahari A; Amin K; Ghahghaie F; Firouzi F
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1691-5. PubMed ID: 16246187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea.
    Lee HS; Park SH; Yang SK; Ye BD; Kim JH; Kim SO; Soh JS; Lee S; Bae JH; Lee HJ; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yoon YS; Yu CS; Kim JH
    Scand J Gastroenterol; 2015 Feb; 50(2):188-96. PubMed ID: 25515241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
    Kappelman MD; Horvath-Puho E; Sandler RS; Rubin DT; Ullman TA; Pedersen L; Baron JA; Sørensen HT
    Gut; 2011 Jul; 60(7):937-43. PubMed ID: 21339206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in inflammatory bowel disease according to patient phenotype and treatment: a Danish population-based cohort study.
    Jess T; Horváth-Puhó E; Fallingborg J; Rasmussen HH; Jacobsen BA
    Am J Gastroenterol; 2013 Dec; 108(12):1869-76. PubMed ID: 23978954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation.
    Kappelman MD; Farkas DK; Long MD; Erichsen R; Sandler RS; Sørensen HT; Baron JA
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):265-73.e1. PubMed ID: 23602821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).
    Henriksen M; Jahnsen J; Lygren I; Sauar J; Schulz T; Stray N; Vatn MH; Moum B;
    Scand J Gastroenterol; 2006 Sep; 41(9):1037-43. PubMed ID: 16938716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study.
    Jess T; Frisch M; Jørgensen KT; Pedersen BV; Nielsen NM
    Gut; 2012 Sep; 61(9):1279-83. PubMed ID: 22184069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
    Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
    Ann Rheum Dis; 2005 Oct; 64(10):1414-20. PubMed ID: 15843454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study.
    Ludvigsson JF; Büsch K; Olén O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
    BMC Gastroenterol; 2017 Jan; 17(1):23. PubMed ID: 28143594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of pediatric population with inflammatory bowel disease.
    Pozler O; Maly J; Bonova O; Dedek P; Frühauf P; Havlickova A; Janatova T; Jimramovsky F; Klimova L; Klusacek D; Kocourkova D; Kolek A; Kotalova R; Marx D; Nevoral J; Petro R; Petru O; Plasilova I; Seidl Z; Sekyrova I; Semendak N; Schreierova I; Stanek J; Sykora J; Sulakova A; Toukalkova L; Travnickova R; Volf V; Zahradnicek L; Zenisková I
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):186-9. PubMed ID: 16456413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer risk in patients with inflammatory bowel disease: a population-based study.
    Bernstein CN; Blanchard JF; Kliewer E; Wajda A
    Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancies in patients with inflammatory bowel disease: a nationwide register study in Finland.
    Jussila A; Virta LJ; Pukkala E; Färkkilä MA
    Scand J Gastroenterol; 2013 Dec; 48(12):1405-13. PubMed ID: 24131389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Hematologic Malignancies in Patients with Inflammatory Bowel Disease: A Meta-Analysis of Cohort Studies.
    Zhou X; Zhang Q; Wang D; Xiang Z; Ruan J; Tang L
    Gut Liver; 2024 Sep; 18(5):845-856. PubMed ID: 38953119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.